{
    "2016-02-02": [
        "RT @adamfeuerstein: $PFE terminated ph2 study of 5HT6 Antagonist on Oct. 23, 2015 due to futility. Disclosed Jan. 29, 2016",
        "RT @JohnCFierce: Pfizer flags a failed PhII Alzheimer's drug study, putting spotlight on rivals $PFE $AXON",
        "RT @megtirrell: $PFE CEO Ian Read: \"Under current law, I do not believe there is any reason why this deal will not close. Full stop.\" $AGN",
        "Pfizer Q4 EPS $0.53 vs $0.52 est, Revenue $14.05B vs $13.56B est $PFE"
    ]
}